Astec LifeSciences share news, announcements and annual reports
NSE: ASTECBSE: 533138Fertilizers & AgrochemicalsSmall Cap
Astec LifeSciences Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Nov 2009
Last close ₹548.55up ₹3.00 (0.55%)BSE ₹549.45
Share price at the NSE close on 2 Nov 2026. Previous close ₹545.55.
2 Nov: open ₹542.00, high ₹562.00, low ₹537.85
52-week range of traded prices to 2 Nov 2026
₹513.40Low, 23 Mar 2026₹941.75High, 26 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,222 Cr1,284th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.65
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −21.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −7.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.99
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 51,24337.4% delivered
Astec LifeSciences results
84 filed, newest first. Page 2 of 2.
Oct 2017
25 Oct · Results
Jul 2017
28 Jul · Results
May 2017
4 May · Results
Jan 2017
25 Jan · Results
Oct 2016
27 Oct · Results
Jul 2016
May 2016
Jan 2016
Nov 2015
Jul 2015
May 2015
Jan 2015
Oct 2014
Aug 2014
May 2014
Jan 2014
Oct 2013
Aug 2013
May 2013
Feb 2013
Nov 2012
Aug 2012
May 2012
4 May · Results
Company has opted the option to submit audited financial results for the entire Financial Year 2011-12. The Company has further informed the Exchange that the Company will not file financial results for the quarter ended on March 31, 2012.
Feb 2012
Nov 2011
Aug 2011
10 Aug · Results
May 2011
Apr 2011
13 Apr · Results
Company will declare and publish Audited Financial Results for the entire financial year ended March 31, 2011 within a period of sixty (60) days from the end of financial year i.e. on or before May 30, 2011 in place of Unaudited quarterly financial results for the quarter ended March 31, 2011, as per SEBI guidelines.
Feb 2011
Nov 2010
Apr 2010
15 Apr · Results
Company will declare and publish Audited Financial Results (Consolidated as well as Standalone) for the entire financial year ended March 31, 2010 within a period of 60 days from the end of financial year i.e. on or before May 30, 2010 in place of Unaudited quarterly financial results for the quarter ended March 31, 2010, as per SEBI guidelines.5 Apr · Results
Company will declare and publish Audited Financial Results (Consolidated as well as Standalone) for the entire financial year March 31, 2010 within a period of three months from the end of financial year i.e. on or before June 30, 2010 in place of Unaudited quarterly financial results for the quarter ended March 31, 2010.